| Literature DB >> 26060341 |
E Sadowska-Krępa1, B Kłapcińska1, T Podgórski2, B Szade3, K Tyl1, A Hadzik4.
Abstract
The purpose of this pilot study was to examine whether regular consumption of an acai berry-based juice blend would affect sprint performance and improve blood antioxidant status and lipid profile in junior athletes. Seven junior hurdlers (17.5±1.2 years) taking part in a pre-season conditioning camp were supplemented once a day, for six weeks, with 100 ml of the juice blend. At the start and the end of the camp the athletes performed a 300-m sprint running test on an outdoor track. Blood samples were taken before and immediately after the test and after 1 h of recovery. Blood antioxidant status was evaluated based on activities of antioxidant enzymes (superoxide dismutase [SOD], catalase [CAT], glutathione peroxidase [GSH-Px], glutathione reductase [GR]), concentrations of non-enzymatic antioxidants (reduced glutathione [GSH], uric acid), total plasma polyphenols, ferric reducing ability of plasma (FRAP), thiobarbituric acid reactive substances (TBARS) and activities of creatine kinase (CK) and lactate dehydrogenase (LDH) as muscle damage markers. In order to evaluate potential health benefits of the acai berry, the post-treatment changes in lipid profile parameters (triglycerides, cholesterol and its fractions) were analysed. Six weeks' consumption of acai berry-based juice blend had no effect on sprint performance, but it led to a marked increase in the total antioxidant capacity of plasma, attenuation of the exercise-induced muscle damage, and a substantial improvement of serum lipid profile. These findings strongly support the view of the health benefits of supplementation with the acai berry-based juice blend, mainly attributed to its high total polyphenol content and the related high in vivo antioxidant and hypocholesterolaemic activities of this supplement.Entities:
Keywords: antioxidants; exercise; junior athletes; lipoproteins; plant polyphenols
Year: 2015 PMID: 26060341 PMCID: PMC4447763 DOI: 10.5604/20831862.1144419
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
Phytochemical analysis of the acai berry-based juice blend
| Measurements | Units | |
|---|---|---|
| FRAP (Ferric reducing ability/antioxidant power) | µmol TE·mL of juice−1 | 15.78 |
| Total polyphenols | mg GAE·mL of juice−1 | 1.98 |
| Total anthocyanins | µg Malvin·mL of juice−1 | 31.30 |
| Total proteins | mg·mL−1 | 6.44 |
| Glucose | mg·mL−1 | 1.79 |
Note: TE – Trolox equivalents, GAE – gallic acid equivalents, Malvin – malvidin 3,5-diglucoside equivalents
Changes in plasma lactate and activities of CK and LDH induced by the dietary treatment
| Variable | Baseline | Post-treatment | Two-way ANOVA results | ||||
|---|---|---|---|---|---|---|---|
| Pre-exercise | Post exercise | After 1 hr recovery | Pre-exercise | Post exercise | After 1 hr recovery | ||
| CK | 137.74 | 242.01 | 196.36 | 135.39 | 213.86 | 180.29 | TE: F = 0.82, P = 0.38, η2=0.02 |
| (U·L−1) | (34.60) | (38.69) | (75.64) | (47.61) | (72.83) | (50.06) | EE: F = 9.54, P = 0.0005, η2=0.34 |
| INT: F = 0.19, P = 0.83, η2=0.01 | |||||||
|
| |||||||
| LDH | 323.42 | 434.43 | 391.71 | 325.15 | 365.62 | 375.07 | TE: F = 2.91, P = 0.09, η2=0.05 |
| (U·L−1) | (51.04) | (63.24) | (41.14) | (52.48) | (50.57) | (57.03) | EE: F = 7.89, P = 0.001, η2=0.28 |
| INT: F = 1.67, P = 0.20, η2=0.06 | |||||||
|
| |||||||
| LA | 3.03 | 16.21 | 3.68 | 3.52 | 14.68 | 3.63 | TE: F = 3.48, P = 0.07, η2=0.01 |
| (mmol·L−1) | (0.32) | (1.97) | (0.55) | (0.20) | (1.32) | (0.77) | EE: F = 1093.7, P = 0.000, η2=0.98 |
| INT: F = 5.82, P = 0.01, η2=0.01 | |||||||
Note: Data are means (SD). Significant differences:
P < 0.05,
P < 0.01 vs. resting values;
P < 0.05 vs. respective values before treatment. TE – treatment effect; EE – exercise effect; INT – interaction
Changes in activities of the blood antioxidant enzymes induced by the dietary treatment
| Variable | Baseline | Post-treatment | Two-way ANOVA results | ||||
|---|---|---|---|---|---|---|---|
| Pre-exercise | Post exercise | After 1 hr recovery | Pre-exercise | Post exercise | After 1 hr recovery | ||
| SOD | 1149.2 | 1109.8 | 1169.8 | 1184.2 | 1187.6 | 1380.7 | TE: F = 2.69, p = 0.109, η2=0.07 |
| (U·gHb−1) | (268.2) | (275.9) | (191.9) | (52.7) | (117.2) | (266.9) | EE: F = 1.44, P = 0.25, η2=0.07 |
| INT: F = 0.65, P = 0.53, η2=0.03 | |||||||
|
| |||||||
| GSH-Px | 31.0 | 29.9 | 28.8 | 34.9 | 31.7 | 27.4 | TE: F = 1.56, P = 0.22, η2=0.03 |
| (U·gHb−1) | (3.5) | (2.9) | (4.9) | (3.9) | (2.7) | (4.0) | EE: F = 5.86, P = 0.01, η2=0.23 |
| INT: F = 1.78, P = 0.18, η2=0.07 | |||||||
|
| |||||||
| CAT | 196.3 | 164.3 | 191.2 | 206.3 | 204.2 | 223.3 | TE: F = 4.21, P = 0.05, η2=0.10 |
| (k·gHb−1) | (68.7) | (41.5) | (34.7) | (14.6) | (43.9) | (37.5) | EE: F = 1.07, P = 0.35, η2=0.05 |
| INT: F = 0.45, P = 0.64, η2=0.02 | |||||||
|
| |||||||
| GR | 31.1 | 37.2 | 35.2 | 31.1 | 36.9 | 48.9 | TE: F = 3.47, P = 0.07, η2=0.06 |
| (U·gHb−1) | (6.7) | (6.0) | (10.6) | (4.0) | (6.8) | (10.3) | EE: F = 7.00, P = 0.001, η2=0.23 |
| INT:F = 3.69, P = 0.01, η2=0.13 | |||||||
Note: Data are means (SD). Significant differences:
P < 0.05 vs. resting values;
P < 0.05 vs. post-exercise values;
P < 0.05 vs. respective values before treatment. TE – treatment effect; EE – exercise effect; INT – interaction
Changes in non-enzymatic antioxidant status and antioxidant defence capacity induced by the dietary treatment
| Variable | Baseline | Post-treatment | Two-way ANOVA results | ||||
|---|---|---|---|---|---|---|---|
| Pre-exercise | Post exercise | After 1 hr recovery | Pre-exercise | Post exercise | After 1 hr recovery | ||
| GSH | 2.79 | 2.21 | 2.04 | 3.57 | 2.61 | 2.30 | TE: F = 8.81, P = 0.001, η2=0.12 |
| (µg·gHb−1) | (0.37) | (0.59) | (0.65) | (0.31) | (0.58) | (0.56) | EE: F = 14.16, P = 0.000, η2=0.38 |
| INT: F = 0.88, P = 0.42, η2=0.03 | |||||||
|
| |||||||
| Uric acid | 6.16 | 8.53 | 10.89 | 6.78 | 9.23 | 10.33 | TE: F = 0.72, P = 0.40, η2=0.01 |
| (mg·dl−1) | (1.00) | (1.26) | (0.53) | (0.51) | (1.03) | (1.11) | EE:F = 66.97, P = 0.000, η2=0.77 |
| INT: F = 1.93, P = 0.16, η2=0.03 | |||||||
|
| |||||||
| Total plasma polyphenols | 1947.1 | 1826.7 | 1943.3 | 2121.7 | 1873.3 | 1930.0 | TE: F = 4.43, P = 0.04, η2=0.07 |
| (mg GAE·L−1) | (85.2) | (129.8) | (56.2) | (135.6) | (93.7) | (117.8) | EE: F = 10.47, P = 0.001, η2=0.32 |
| INT: F = 2.83, P = 0.07, η2=0.09 | |||||||
|
| |||||||
| FRAP | 957.0 | 1004.2 | 1033.5 | 1091.7 | 1118.3 | 1164.2 | TE: F = 20.47, P = 0.000, η2=0.34 |
| (µmol TE·L−1) | (49.7) | (86.8) | (74.2) | (81.2) | (85.6) | (140.8) | EE: F = 2.37, P = 0.11, η2=0.08 |
| INT: F = 0.05, P = 0.95, η2=0.01 | |||||||
|
| |||||||
| TBARS | 6.37 | 6.88 | 6.42 | 6.01 | 6.45 | 5.58 | TE: F = 2.44, P = 0.13, η2=0.06 |
| (µmol·L−1) | (1.32) | (1.07) | (1.68) | (0.40) | (0.69) | (1.14) | EE: F = 1.30, P = 0.28, η2=0.07 |
| INT: F = 0.8, P = 0.84, η2=0.01 | |||||||
Note: Data are means (SD). Significant differences:
P < 0.05,
P < 0.01,
P < 0.001 vs. the resting values;
P < 0.05 vs. the respective values before treatment. TE - Treatment effect; EE - Exercise effect; INT - Interaction
Changes in serum lipids and lipid ratios induced by the dietary treatment
| Variable | Baseline | Post-treatment | Two-way ANOVA results | ||||
|---|---|---|---|---|---|---|---|
| Pre-exercise | Post exercise | After 1 hr recovery | Pre-exercise | Post exercise | After 1 hr recovery | ||
| T-C | 159.2 | 167.7 | 171.1 | 133.7 | 157.4 | 139.8 | TE: F = 19.66, P = 0.000, η2=0.30 |
| (mg·dl−1) | (17.5) | (13.4) | (14.5) | (12.9) | (18.1) | (20.3) | EE: F = 3.40, P = 0.05, η2=0.11 |
| INT: F = 1.53, P = 0.23, η2=0.05 | |||||||
|
| |||||||
| HDL-C | 50.0 | 52.1 | 50.5 | 59.9 | 64.9 | 57.6 | TE: F = 8.99, P = 0.01, η2=0.19 |
| (mg·dl−1) | (11.4) | (10.5) | (15.8) | (9.00) | (8.5) | (6.8) | EE: F = 0.69, P = 0.51, η2=0.03 |
| INT: F = 0.25, P = 0.78, η2=0.01 | |||||||
|
| |||||||
| LDL-C | 90.4 | 91.4 | 98.9 | 59.6 | 74.0 | 65.7 | TE: F = 27.54, P = 0.000, η2=0.41 |
| (mg·dl−1) | (12.3) | (15.9) | (20.1) | (15.5) | (18.0) | (17.8) | EE: F = 0.93, P = 0.40, η2=0.03 |
| INT: F = 0.91, P = 0.41, η2=0.03 | |||||||
|
| |||||||
| TG | 93.8 | 121.1 | 108.6 | 71.5 | 92.3 | 82.9 | TE: F = 9.49, P = 0.01, η2=0.19 |
| (mg·dl−1) | (30.4) | (39.2) | (35.4) | (10.6) | (13.2) | (18.3) | EE: F = 2.79, P = 0.07, η2=0.11 |
| INT: F = 0.05, P = 0.95, η2=0.01 | |||||||
|
| |||||||
| T-C/HDL-C | 3.32 | 3.41 | 3.80 | 2.27 | 2.45 | 2.44 | TE:F = 15.41, P = 0.001, η2=0.30 |
| (0.75) | (1.14) | (1.69) | (0.39) | (0.34) | (0.37) | EE: F = 0.45, P = 0.64, η2=0.02 | |
| INT: F = 0.18, P = 0.83, η2=0.01 | |||||||
|
| |||||||
| LDL-C/HDL-C | 1.93 | 1.89 | 2.28 | 1.03 | 1.16 | 1.15 | TE:F = 17.32, P = 0.001, η2=0.32 |
| (0.66) | (0.81) | (1.26) | (0.37) | (0.34) | (0.34) | EE: F = 0.42, P = 0.66, η2=0.02 | |
| INT: F = 0.28, P = 0.76, η2=0.01 | |||||||
|
| |||||||
| TG/HDL-C | 1.95 | 2.59 | 2.64 | 1.21 | 1.42 | 1.47 | TE: F = 7.39, P = 0.01, η2=0.17 |
| (0.72) | (1.75) | (2.27) | (0.19) | (0.13) | (0.40) | EE: F = 0.64, P = 0.53, η2 = 0.03 | |
| INT: F = 0.14, P = 0.87, η2=0.01 | |||||||
|
| |||||||
| AIP | -0.093 | -0.003 | -0.023 | -0.283 | -0.208 | -0.207 | TE: F = 15.50, P = 0.001, η2=0.29 |
| (0.15) | (0.21) | (0.26) | (0.07) | (0.04) | (0.12) | EE: F = 1.13, P = 0.33, η2=0.05 | |
| INT:F = 0.18, P = 0.98, η2=0.00 | |||||||
Note: Data are means (SD). Significant differences:
P < 0.05 vs. the respective values before treatment. TE – treatment effect; EE – exercise effect; INT – interaction
Spearman's rank correlation coefficients between selected variables
| Variables |
|
|
|---|---|---|
| LA & total plasma polyphenols | -0.43 | <0.005 |
| CK & total plasma polyphenols | -0.43 | <0.004 |
| GSH & total plasma polyphenols | 0.47 | <0.002 |
| TBARS & total plasma polyphenols | -0.32 | <0.05 |
| T-C & total plasma polyphenols | -0.33 | <0.05 |
| LDL & total plasma polyphenols | -0.28 | NS (P = 0.07) |
| T-C/HDL-C & total plasma polyphenols | -0.26 | NS (P = 0.09) |
| TG/HDL-C & total plasma polyphenols | -0.42 | <0.005 |
| AIP & total plasma polyphenols | -0.42 | <0.01 |
| GSH & FRAP | 0.34 | <0.02 |
| UA & FRAP | 0.26 | NS (P = 0.09) |
| TG & FRAP | -0.31 | <0.04 |
| T-C/HDL-C & FRAP | -0.27 | NS (P = 0.08) |
| TG/HDL-C & FRAP | -0.33 | <0.03 |
| AIP & FRAP | -0.33 | <0.05 |